ArticleCancer discovery2017
The Path of Most Resistance: Transdifferentiation Underlies Exceptional Nonresponses to Androgen Receptor Pathway Inhibition in Prostate Cancer.
Seema Sinha et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it